Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

793 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.
Fujikawa K, Aratake K, Kawakami A, Aramaki T, Iwanaga N, Izumi Y, Arima K, Kamachi M, Tamai M, Huang M, Nakamura H, Nishiura Y, Origuchi T, Ida H, Eguchi K. Fujikawa K, et al. Ann Rheum Dis. 2007 Jan;66(1):136-7. doi: 10.1136/ard.2006.056804. Ann Rheum Dis. 2007. PMID: 17178762 Free PMC article. No abstract available.
Early prediction of rheumatoid arthritis by serological variables and magnetic resonance imaging of the wrists and finger joints: results from prospective clinical examination.
Tamai M, Kawakami A, Uetani M, Takao S, Rashid H, Tanaka F, Fujikawa K, Aramaki T, Nakamura H, Iwanaga N, Izumi Y, Arima K, Aratake K, Kamachi M, Huang M, Origuchi T, Ida H, Aoyagi K, Eguchi K. Tamai M, et al. Among authors: fujikawa k. Ann Rheum Dis. 2006 Jan;65(1):134-5. doi: 10.1136/ard.2005.043075. Ann Rheum Dis. 2006. PMID: 16344501 Free PMC article. No abstract available.
Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics.
Kawashiri SY, Kawakami A, Iwamoto N, Fujikawa K, Aramaki T, Tamai M, Arima K, Ichinose K, Kamachi M, Yamasaki S, Nakamura H, Origuchi T, Ida H, Eguchi K. Kawashiri SY, et al. Among authors: fujikawa k. Mod Rheumatol. 2010 Feb;20(1):40-5. doi: 10.1007/s10165-009-0235-4. Epub 2009 Oct 3. Mod Rheumatol. 2010. PMID: 19802651
Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
Fujikawa K, Kawakami A, Hayashi T, Iwamoto N, Kawashiri SY, Aramaki T, Ichinose K, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Ida H, Origuchi T, Eguchi K. Fujikawa K, et al. Mod Rheumatol. 2010 Feb;20(1):86-9. doi: 10.1007/s10165-009-0232-7. Epub 2009 Oct 8. Mod Rheumatol. 2010. PMID: 19812889
A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies.
Tamai M, Kawakami A, Uetani M, Takao S, Arima K, Iwamoto N, Fujikawa K, Aramaki T, Kawashiri SY, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Aoyagi K, Eguchi K. Tamai M, et al. Among authors: fujikawa k. Arthritis Rheum. 2009 Jun 15;61(6):772-8. doi: 10.1002/art.24711. Arthritis Rheum. 2009. PMID: 19479686 Free article.
Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs.
Kawashiri SY, Kawakami A, Iwamoto N, Fujikawa K, Aramaki T, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Tsurumoto T, Kono M, Shindo H, Ida H, Origuchi T, Eguchi K. Kawashiri SY, et al. Among authors: fujikawa k. J Rheumatol. 2009 Nov;36(11):2397-402. doi: 10.3899/jrheum.090132. Epub 2009 Oct 1. J Rheumatol. 2009. PMID: 19797510
793 results